Diagnostic medical tourism is the quietest, highest-value corner of the whole medical travel market, and almost nobody plans for it. Everyone pictures the dental trip or the knee replacement. Far fewer people think about the test that comes before any of that – the scan that tells you whether the knee needs replacing at all, or whether the fatigue you’ve been ignoring is nothing or something.

In Canada, that test is a queue. Abroad, it’s a product. This deep dive is the third stop in our medical tourism series, and it covers what executive health screening actually is, what it costs, where to get it, and the one risk the brochures never mention. I’m not a doctor, and none of this is medical advice. It’s a framework.

Medical tourism for Canadians is no longer a fringe topic. In 2025, an estimated 105,529 Canadians travelled outside the country for non-emergency medical treatment — a 66% jump from a decade earlier. That’s not a statistic about desperate people making bad decisions. That’s a market signal. When six figures’ worth of your fellow citizens quietly pay out of pocket — after already paying taxes into a universal system — to get a hip, a scan, or a mouth full of implants somewhere else, the rational response isn’t outrage. It’s research.

This post kicks off a new series on Sovereign Canadian, running parallel to our real estate investing series. Same approach: country by country, procedure by procedure, with real numbers, honest risk assessments, and none of the brochure language. This introduction covers the landscape – why Canadians leave, the procedures that make the most sense to get abroad, the ten destinations that matter, and how to think about the whole thing like an adult managing a portfolio rather than a patient hoping for the best.